Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZhichuangShuang is an approved over-the-counter (OTC) topical medication developed and manufactured by Hongqi Pharmaceuticals, a subsidiary of Fosun Pharma. It is a traditional Chinese medicine (TCM) formulation primarily indicated for the treatment of various types of hemorrhoids, including internal, external, and mixed hemorrhoids, as well as anal fissures. The product is formulated as a cream and contains a combination of active ingredients such as artificial musk, artificial calculus bovis, pearl, borneol, amber, calamine, and borax. These ingredients work synergistically to provide anti-inflammatory, analgesic, astringent, and hemostatic effects. ZhichuangShuang is designed to reduce swelling, alleviate local pain and itching, and promote the healing of damaged anal tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhichuangshuang.